[1]
2021. Impact of three consecutive intravenous doses of tocilizumab in severe COVID-19 pneumonia: a retrospective cohort study. Microbes, Infection and Chemotherapy. 1, (Dec. 2021), e1251. DOI:https://doi.org/10.54034/mic.e1251.